These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 19268911)

  • 1. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates visceral mitochondrial activity and CD14 expression following thoracic aortic ischemia-reperfusion.
    Stone DH; Albadawi H; Conrad MF; Entabi F; Stoner MC; Casey PJ; Cambria RP; Watkins MT
    Am J Surg; 2009 Aug; 198(2):250-5. PubMed ID: 19268911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of PJ34 on spinal cord tissue viability and gene expression in a murine model of thoracic aortic reperfusion injury.
    Stone DH; Conrad MF; Albadawi H; Entabi F; Stoner MC; Cambria RP; Watkins MT
    Vasc Endovascular Surg; 2009; 43(5):444-51. PubMed ID: 19640911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(adenosine diphosphate ribose) polymerase inhibition modulates spinal cord dysfunction after thoracoabdominal aortic ischemia-reperfusion.
    Casey PJ; Black JH; Szabo C; Frosch M; Albadawi H; Chen M; Cambria RP; Watkins MT
    J Vasc Surg; 2005 Jan; 41(1):99-107. PubMed ID: 15696051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyadenosine diphosphate-ribose polymerase inhibition modulates skeletal muscle injury following ischemia reperfusion.
    Hua HT; Albadawi H; Entabi F; Conrad M; Stoner MC; Meriam BT; Sroufe R; Houser S; Lamuraglia GM; Watkins MT
    Arch Surg; 2005 Apr; 140(4):344-51; discussion 351-2. PubMed ID: 15837884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. PJ34, a poly-ADP-ribose polymerase inhibitor, modulates renal injury after thoracic aortic ischemia/reperfusion.
    Stone DH; Al-Badawi H; Conrad MF; Stoner MC; Entabi F; Cambria RP; Watkins MT
    Surgery; 2005 Aug; 138(2):368-74. PubMed ID: 16153449
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local administration of the Poly ADP-Ribose Polymerase (PARP) inhibitor, PJ34 during hindlimb ischemia modulates skeletal muscle reperfusion injury.
    Conrad MF; Albadawi H; Stone DH; Crawford RS; Entabi F; Watkins MT
    J Surg Res; 2006 Oct; 135(2):233-7. PubMed ID: 16872633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poly adenosine diphosphate-ribose polymerase inhibitor PJ34 abolishes systemic proinflammatory responses to thoracic aortic ischemia and reperfusion.
    Black JH; Casey PJ; Albadawi H; Cambria RP; Watkins MT
    J Am Coll Surg; 2006 Jul; 203(1):44-53. PubMed ID: 16798486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of PJ-34 PARP-inhibitor on rat liver microcirculation and antioxidant status.
    Szijártó A; Batmunkh E; Hahn O; Mihály Z; Kreiss A; Kiss A; Lotz G; Schaff Z; Váli L; Blázovics A; Geró D; Szabó C; Kupcsulik P
    J Surg Res; 2007 Sep; 142(1):72-80. PubMed ID: 17612561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of poly(ADP-ribose) polymerase to postischemic blood-brain barrier damage in rats.
    Lenzsér G; Kis B; Snipes JA; Gáspár T; Sándor P; Komjáti K; Szabó C; Busija DW
    J Cereb Blood Flow Metab; 2007 Jul; 27(7):1318-26. PubMed ID: 17213862
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 5-Aminoisoquinolinone, a novel inhibitor of poly(adenosine disphosphate-ribose) polymerase, reduces microvascular liver injury but not mortality rate after hepatic ischemia-reperfusion.
    Khandoga A; Biberthaler P; Enders G; Krombach F
    Crit Care Med; 2004 Feb; 32(2):472-7. PubMed ID: 14758166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The therapeutic effects of PJ34 [N-(6-oxo-5,6-dihydrophenanthridin-2-yl)-N,N-dimethylacetamide.HCl], a selective inhibitor of poly(ADP-ribose) polymerase, in experimental allergic encephalomyelitis are associated with immunomodulation.
    Scott GS; Kean RB; Mikheeva T; Fabis MJ; Mabley JG; Szabó C; Hooper DC
    J Pharmacol Exp Ther; 2004 Sep; 310(3):1053-61. PubMed ID: 15159442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pneumonia-induced sepsis and gut injury: effects of a poly-(ADP-ribose) polymerase inhibitor.
    Lobo SM; Orrico SR; Queiroz MM; Cunrath GS; Chibeni GS; Contrin LM; Cury PM; Burdmann EA; de Oliveira Machado AM; Togni P; De Backer D; Preiser JC; Szabó C; Vincent JL
    J Surg Res; 2005 Dec; 129(2):292-7. PubMed ID: 16139303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory effects of PJ34, a poly(ADP-ribose) polymerase inhibitor, in transient focal cerebral ischemia in mice.
    Haddad M; Rhinn H; Bloquel C; Coqueran B; Szabó C; Plotkine M; Scherman D; Margaill I
    Br J Pharmacol; 2006 Sep; 149(1):23-30. PubMed ID: 16865091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction of hemorrhagic transformation by PJ34, a poly(ADP-ribose)polymerase inhibitor, after permanent focal cerebral ischemia in mice.
    Haddad M; Beray-Berthat V; Coqueran B; Palmier B; Szabo C; Plotkine M; Margaill I
    Eur J Pharmacol; 2008 Jun; 588(1):52-7. PubMed ID: 18468597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of poly (adenosine diphosphate-ribose) polymerase inhibitors on biochemical changes in testicular ischemia-reperfusion injury.
    Bozlu M; Eskandari G; Cayan S; Canpolat B; Akbay E; Atik U
    J Urol; 2003 May; 169(5):1870-3. PubMed ID: 12686864
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PJ34, a poly adenosine diphosphate-ribose polymerase inhibitor, attenuates chromate-induced nephrotoxicity.
    Yam-Canul P; Chirino YI; Sánchez-González DJ; Martínez-Martínez CM; Cruz C; Pedraza-Chaverri J
    Basic Clin Pharmacol Toxicol; 2008 May; 102(5):483-8. PubMed ID: 18331393
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The novel PARP inhibitor 5-aminoisoquinolinone reduces the liver injury caused by ischemia and reperfusion in the rat.
    Mota-Filipe H; Sepodes B; McDonald MC; Cuzzocrea S; Pinto R; Thiemermann C
    Med Sci Monit; 2002 Nov; 8(11):BR444-53. PubMed ID: 12444369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The parp-1 inhibitor ino-1001 facilitates hemodynamic stabilization without affecting DNA repair in porcine thoracic aortic cross-clamping-induced ischemia/reperfusion.
    Hauser B; Gröger M; Ehrmann U; Albicini M; Brückner UB; Schelzig H; Venkatesh B; Li H; Szabó C; Speit G; Radermacher P; Kick J
    Shock; 2006 Jun; 25(6):633-40. PubMed ID: 16721272
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of poly(ADP-ribose) polymerase activation in the pathogenesis of cardiopulmonary dysfunction in a canine model of cardiopulmonary bypass.
    Szabó G; Soós P; Bährle S; Zsengellér Z; Flechtenmacher C; Hagl S; Szabó C
    Eur J Cardiothorac Surg; 2004 May; 25(5):825-32. PubMed ID: 15082289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined therapy with PJ34, a poly(ADP-ribose)polymerase inhibitor, reduces tissue plasminogen activator-induced hemorrhagic transformations in cerebral ischemia in mice.
    Haddad M; Beray-Berthat V; Coqueran B; Plotkine M; Marchand-Leroux C; Margaill I
    Fundam Clin Pharmacol; 2013 Aug; 27(4):393-401. PubMed ID: 22436003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.